Label: MUCUS RELIEF- guaifenesin tablet, extended release

  • NDC Code(s): 70000-0730-1
  • Packager: LEADER/ Cardinal Health 110, Inc.
  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: Abbreviated New Drug Application

Drug Label Information

Updated April 16, 2025

If you are a consumer or patient please visit this version.

  • Drug Facts
  • Active ingredient (in each extended-release tablet)
    Guaifenesin, USP 1200 mg
  • Purpose
    Expectorant
  • Uses
    helps loosen phlegm (mucus) and thin bronchial secretions to rid the bronchial passageways of bothersome mucus and make coughs more productive
  • Warnings
  • Do not use
    for children under 12 years of age
  • Ask a doctor before use if you have
    persistent or chronic cough such as occurs with smoking, asthma, chronic bronchitis, or emphysema cough accompanied by too much phlegm (mucus)
  • Stop use and ask a doctor if
    cough lasts more than 7 days, comes back, or occurs with fever, rash, or persistent headache. These could be signs of a serious illness.
  • If pregnant or breast-feeding,
    ask a health professional before use.
  • Keep out of reach of children.
    In case of overdose, get medical help or contact a Poison Control Center (1-800-222-1222) right away.
  • Directions
    do not crush, chew, or break extended-release tablet - take with a full glass of water - this product can be administered without regard for the timing of meals - adults and children 12 years of age ...
  • Other information
    store at 20-25°C (68-77°F)
  • Inactive ingredients
    colloidal silicon dioxide, copovidone, FD&C blue no. 1 aluminum lake, hypromellose, magnesium stearate, maltodextrin, microcrystalline cellulose, povidone (K-30), sodium starch glycolate, stearic ...
  • Questions or comments?
    Call - 1-877-290-4008
  • PRINCIPAL DISPLAY PANEL
  • PRINCIPAL DISPLAY PANEL
    LC-guaifenesin-28s
  • INGREDIENTS AND APPEARANCE
    Product Information